Cargando…
Clostridium difficile Testing Algorithm: Is There a Difference in Patients Who Test Positive by Enzyme Immunoassay vs. Those Who Only Test Positive by Nucleic Acid Amplification Methodology?
BACKGROUND: Testing for Clostridium difficile infection (CDI) commonly involves checking for the presence of toxins A and B by enzyme immunoassay (EIA) or nucleic acid amplification (NAA). The former is very specific, but not very sensitive. The latter is very sensitive. Beginning in 2011, our hospi...
Autores principales: | Polak, Jonathan, Odili, Ogheneruona, Craver, Mary Ashleigh, Mayen, Anthony, Purrman, Kyle, Rahman, Asem, Sang, Charlie Joseph, Cook, Paul P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631102/ http://dx.doi.org/10.1093/ofid/ofx163.981 |
Ejemplares similares
-
Clinical Correlation of a Clostridium difficile Testing Algorithm Reflexing PCR Positive Specimens to Toxin Enzyme Immunoassay (EIA)
por: Rios, Maria Bueno, et al.
Publicado: (2017) -
Controversies in Clostridium difficile testing
por: Fedorko, Daniel P.
Publicado: (2002) -
A pilot study of PCR community mass testing for COVID-19: who attends and who tests positive?
por: Levin, Kate, et al.
Publicado: (2021) -
Etiology of Infectious Diarrhea in Patients Tested for Clostridium difficile: If It Isn’t Clostridium difficile, What Is It?
por: Kwon, Jennie H, et al.
Publicado: (2017) -
Differences in Clinical Characteristics and Outcomes of Patients with Community-Onset Clostridium difficile Infection who Tested Positive by EIA Compared with NAAT through a Two-Step Algorithm
por: Phipps, Erin C, et al.
Publicado: (2017)